WASHINGTON, Aug. 5 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration is withdrawing approval for 39 drug applications after the products were voluntarily pulled from the market. The action impacts a variety of prescription medicines, including treatments for blood pressure, diabetes and mental health conditions.

The decision comes after drug makers, including major pharmaceutical companies like Pfizer and AstraZeneca, informed the agency that t . . .

Click here for more information about our products